Tianchong Wu

Shenzhen Luohu People's Hospital

Papers

1

Total Citations

19

H-Index

1

About

Tianchong Wu is a leading hepatobiliary surgeon whose research focuses on advancing minimally invasive surgical techniques for liver cancer, particularly hepatocellular carcinoma (HCC). His major contributions center on comparing robotic and laparoscopic approaches in major hepatectomy, with a landmark 2022 study from a single institution demonstrating that robotic surgery yields superior short-term outcomes, including reduced blood loss and shorter hospital stays. This work, cited 19 times, has helped establish robotic hepatectomy as a viable, potentially safer alternative to traditional laparoscopic methods for complex liver resections. Wu’s research is pivotal in refining surgical protocols, improving patient recovery, and expanding the role of robotics in oncologic surgery. His findings are widely referenced by surgeons and researchers seeking evidence-based guidance on operative techniques, underscoring his impact on clinical practice and surgical innovation. Through rigorous comparative studies, Wu continues to shape the future of minimally invasive liver surgery, making him a key figure in the field.

Research Focus

Key Achievements

1
H-Index
1
Papers
19
Total Citations
19
Avg Citations/Paper
🏆 Most Cited Paper
Robotic versus laparoscopic major hepatectomy for hepatocellular carcinoma: short-term outcomes from a single institution
19 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Shenzhen Luohu People's Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago